VX-970 (M6620)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VX-970 (M6620), covering 2022-04-12 to 2023-05-19. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors [Phase 1]